reviewEuropean Journal of Medicinal ChemistryJan 13, 2016Closed access

PI3K/Akt/mTOR and Ras/Raf/MEK/ERK signaling pathways inhibitors as anticancer agents: Structural and pharmacological perspectives

VAVivek AsatiDKDebarshi Kar MahapatraSKSanjay Kumar Bharti

Guru Ghasidas Vishwavidyalaya

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

613
total citations
FWCI
23.33
Percentile
100%
References
158
Citations per year

Authors

3

Topics & keywords

Topics
Keywords
  • PI3K/AKT/mTOR pathway
  • Protein kinase B
  • MAPK/ERK pathway
  • Signal transduction
  • Kinase
  • Cancer research
  • Carcinogenesis
  • Chemistry
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding